Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -8.86K | -100% | $0.00* | 0 | Apr 15, 2022 | Common Stock | 8.86K | Direct | F2, F5 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -1.38K | -11.11% | $0.00 | 11.1K | Apr 15, 2022 | Common Stock | 1.38K | Direct | F2, F6 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -862 | -100% | $0.00* | 0 | Apr 15, 2022 | Common Stock | 862 | Direct | F2, F5 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2.32K | -20% | $0.00 | 9.28K | Apr 15, 2022 | Common Stock | 2.32K | Direct | F2, F7 | |
transaction | MRVL | Restricted Stock Units | Award | $0 | +15.7K | $0.00 | 15.7K | Apr 15, 2022 | Common Stock | 15.7K | Direct | F2, F8 |
Id | Content |
---|---|
F1 | Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). |
F2 | Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. |
F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
F4 | Shares are held in a revocable trust. Dean and Megan Jarnac are trustees of the trust, of which their children are the beneficiaries. |
F5 | Grant is fully vested. |
F6 | The remaining RSUs vest quarterly on each of 04/15/2022, 07/15/2022, 10/15/2022, 01/15/2023, 04/15/2023, 07/15/2023, 10/15/2023, 01/15/2024 and 04/15/2024. |
F7 | The remaining RSU's will vest on 07/15/2022, 10/15/2022, 01/15/2023 and 04/15/2023. |
F8 | The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |